ArticleJournal of asthma and allergy2021

Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program.

Raffaele Campisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.